Role Purpose
We are seeking an experienced Medical Science Liaison (MSL) to support an Advanced Targeted Therapies portfolio in a competitive and evolving treatment landscape.
This role is responsible for scientific engagement across the full product lifecycle, from pre-launch preparation through launch execution and post-launch optimization, while maintaining the highest standards of scientific integrity and compliance.
Key Responsibilities:
Scientific Engagement & KOL Partnership (Ongoing Across All Stages)
- Establish and maintain long-term, credible scientific relationships with KOLs, specialists, and academic institutions (Medical School)
- Act as a trusted scientific partner in complex discussions involving:
- Institutional treatment pathways
- Formulary decisions
- System-driven therapy changes
- Ensure consistent, high-quality scientific exchange across Rheumatology, Immunology, and relevant adjacent specialties.
Internal Collaboration
- Collaborate closely with Medical Affairs, Market Access, and Commercial teams to ensure scientific alignment throughout the product lifecycle.
- Support internal education on disease areas, emerging evidence, and evolving treatment landscapes.
- Provide ongoing insights on guideline changes, healthcare system dynamics, and HCP perceptions.
Pre-Launch Phase (Market Preparation & Scientific Readiness)
- Conduct disease-state education and scientific exchange aligned with pre-approval regulations.
- Identify, map, and engage future key opinion leaders (KOLs) and priority institutions
- Gather and synthesize early field medical insights to support:
- Medical strategy development
- Scientific narrative and evidence planning
- Launch readiness activities
- Support internal cross-functional pre-launch planning by providing scientific input on:
- Unmet medical needs
- Treatment landscape and evolving standards of care
- Anticipated switching and sequencing considerations
Launch Phase (Scientific Activation & Early Adoption)
- Lead high-quality peer-to-peer scientific exchange during the initial launch period
- Support scientific education activities, including advisory boards, medical meetings, and launch symposia
- Act as a trusted scientific partner in discussions around:
- Advanced targeted therapy positioning
- Treatment sequencing and early switching considerations
- Address scientific questions related to comparative data, safety, and patient selection in a compliant, non-promotional manner
Post-Launch Phase (Optimization & Lifecycle Support)
- Support ongoing real-world evidence and long-term safety discussions as clinical experience evolves
- Navigate formulary-driven and policy-led treatment changes, maintaining scientific neutrality and credibility
- Lead scientific discussions related to:
- Treatment optimization
- Switching and persistence
- Patient-level considerations in real-world practice
- Continuously collect and communicate post-launch field insights to inform lifecycle management and future indication planning
Compliance & Governance:
- Ensure all scientific activities comply with local regulations, internal SOPs, and ethical standards
Pharmacovigilance:
- Identify, document, and report adverse events and special situations in compliance with local PV requirements and internal SOPs
- Reinforce adverse event reporting awareness during scientific interactions with HCPs and internal teams
- Coordinate with PV and Medical teams to support ongoing safety monitoring and follow-up
Required Qualifications:
- Advanced degree in Life Sciences (PharmD, PhD, MSc, or equivalent)
- Experience as an MSL or Medical role in specialty advanced targeted therapiesportfolio. Proven Dermatology, Immunology,Gastroenterology (IBD) Oncology / Hematology can apply
- Open to non MSL background but must win Dermatology, Immunology,Gastroenterology (IBD) in key medical school
Key Competencies We Value:
- High scientific credibility and confidence in peer-to-peer discussions
- Ability to handle sensitive switching conversations with maturity and neutrality
- Pre-launch scientific engagement
- Competitive, mature therapy classes
- Treatment positioning, sequencing, and switching discussions
Package and Benefits:
Offered fix compensation range 1.45MB to 1.7MB annum plus other monthly necessary allowance, performance bonus and other benefits.
